Nancy Madinger, MD

Professional Titles

• Medical Director, UCH Clinical Microbiology Laboratory

Recognitions

• Savin award, Dept of Pathology, UCD (2010)
  Excellence in Teaching
• Excellence in Education Administration, Academy of Medical Educators, UCD (2009)
  

Research Interests

My principal activities are Medical Director of the Clinical Microbiology Laboratory for University of Colorado Hospital, teaching and patient care. I participate in a number of studies which involve antimicrobial resistance surveys, new diagnostic methods, molecular epidemiology for outbreak investigations at UCH, and clinical studies of new antimicrobial agents. I am actively involved in the HIV primary care program at UCH and have interests in transplant infectious diseases and international health.

Publications

• Barron MA, Lay M, Madinger NE. Successful Treatment of Craniofacial Zygomycosis With Surgery and High-Dose Liposomal Amphotericin B in a Hodgkin’s Patient After Allogeneic Hematopoietic Stem Cell Transplantation. J Clin Microbiol. 2005; 43(4)
• Wyles DL, Patel A, Madinger N, Bessesen M, Krause PR, Weinberg A. Development of Herpes Simplex Virus Disease in Patients Receiving Cidofovir. Clin Infect Dis. 2005;41:676-680
• Barron MA, Wood PA, Campbell G, Madinger NE. Septic platelet transfusion reactions due to Staphylococus aureus. 16th Annual Scientific Meeting of SHEA, Chicago, 2006
• Singh N, Aguado J, Bonatti H, Forrest G, Barron M, Madinger N, Fortun J, and Zygomycosis Treatment Study Group. Risk factors for zygomycosis in solid organ transplant (SOT) recipients: a prospective, case controlled, multicenter, international study. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, 2007.
• Patterson TF, Kirkpatrick WR, Alexander B. Danziger L, Freifeld A, Goff D, Greene J, HIgh K, Ippoliti C, Landovitz R, Madinger N, Pankey G, Pitrak D, Schuster M, Segal BH, Magalhaes-Silverman, Turett G, Vance E, Wingard J, Graybill JR. Efficacy and Safety of Caspofungin (CAS) in a Real Work Clinical Setting. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, 2007.
• Barron, MA, Woods, PA, Campbell, G, Madinger, NE. Septic Platelet Transfusion Reactions Due to Staphylococcus Aureus. Infection Control and Hospital Epidemiology, 2009;30:98-100.
• Howe R, Dillon S, Rogers L, McCarter M, Kelly C, Gonzalez R, Madinger N, Wilson C. Evidence for Dendritic Cell-Dependent CD4+ T Helper-1 Type Responses to Commensal Bacteria in Normal Human Intestinal Lamina Propria. Clin Immunol. 2009; xx: xx-xx
• Jenkins, TC, McCollister, BD, Sharma, R, McFann, KK, Madinger, NE, Barron, MA, Bessessen, M, Price, CS, Burman, WJ. Epidemiology of health care-associated bloodstream infections caused by USA300 strains of methicillin-resistant Staphylococcus aureus in three affiliated hospitals. Infection Control and Hospital Epidemiology. 2009;30:233-41.
• 17. Pisney L, Barron MA, Kassner,L, Havens D, Madinger NE. Carbapenem-Resistant Enterobacteriaceae Rectal Screening During an Outbreak of New Delhi Metallo-ß-Lactamase Producing Klebsiella pneumoniae at an Acute-Care Hospital. Infection Control Hospital Epidemiol. Infect Control Hosp Epidemiol 2014;35(4): 434-436
• DeGroote MA, Gills S, Calado Nogueira de Moura V, Gibbs S, Burgess W, Richardson K, Kasperbauer S, Madinger N, Jackson M. Analysis of a Panel of Rapidly Growing Mycobacteria for Resistance to Aldehyde-based Disinfectants. Am J Infect Control. 2014.
• Barron, MA and Madinger, Ne. “Prevention and Management of Opportunistic Fungal Infections in the Immunosuppressed Host, Part 1: Review of Antifungal Treatments and Prophylaxis. Infections in Medicine. 2008;25:448-473
• Barron, MA and Madinger, NE. “Prevention and Management of Opportunistic Fungal Infections in the Immunosuppressed Host, Part 2: Candida and Aspergillus. Infections in Medicine. 2008;25:
• Barron, MA and Madinger, NE. “Prevention and Management of Opportunistic Fungal Infections in the Immunosuppressed Host, Part 3: Cryptococcosis, Histoplasmosis, Coccidiodomycosis, and Emerging Molds. Infections in Medicine. 2008;25:
• Singh, N, Aguado, J, Bonatti, H, Forrest, G, Barron, M, Madinger, N, Fortun, J, and the Zygomycetes Treatment Study Group. Unique Propensity of Liver Transplant Recipients to Disseminated Disease and Earlier Onset of Post-transplant Zygomycosis: Results from a Prospective, Multicenter Study.48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/Infectious Diseases Society of America, Washington, D.C. , 2008
• Jenkins TC, McCollister B, Sharma R, Madinger N, Barron M, Bessesen M, Price CS, Burman WJ. Epidemiology of Health Care-Associated MRSA USA300 Bloodstream Infections. 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, D.C., 2008.
• Albert RK, Connett J, Bailey WC, Casaburi R, Cooper JAD, Criner GC, Curtis JL, Dransfield MT, Han MK, Lazarus SC, Make B, Marchetti N, Martinez FJ, Madinger NE, McEvoy C, Niewoehner D, Parsasz J, Price CS, Reilly J, Scanlon PD, Scierba FC, Scharf SM, Washko GR, Woodruff PG, Anthonisen NR. Azithromycin for Prevention of COPD Exacerbations. N Engl J Med. 2011; 365:689-698
• Gibbs S, Calado Nogueira de Moura V, DeGroote MA, Madinger N, Svetlíková Z, Thomas V, Richardson K, McDonnell G, Jackson M. Correlates of disinfectant-resistance in Rapidly-Growing nontuberculous mycobacteria. In: Program and Abstracts of the American Thoracic Society International Conference, Denver, May 13-15, 2011
• Courtney C, Goodman S, McDaniel J, Madinger N, Chatterjee A, Nagpal P.Photoexcited Quantum Dots for Killing Multidrug-Resistant Bacteria. Nature Materials. 2016 May;15(5):529-34
• C, Goodman S, Li F, Madinger N, Nagpal P, Chatterjee A. Photoexcited Quantum Dots Potentiate Antibiotic Activity in Multidrug-Resistant Bacteria. In: Program and Abstracts of Annual Meeting of the American Institute of Chemical Engineers, San Francisco, Nov 13-18, 2016. Abstract #46
• Erickson KE, Madinger NE, Chatterjee A. Draft genome sequence for a clinical isolate of vancomycin resistant Enterococcus faecalis. Genome Announc. 2016;4(3):e00584-16
• Erickson KE, Madinger NE, Chatterjee A. Draft genome sequences for clinical isolates of multi-drug resistant Acinetobacter baumannii. Genome Announc. 5:e01547-16
• 23. Courtney CM, Goodman SM, Nagy TA, Levy M, Bhusal P, Madinger NE, Detweiler CS, Nagpal P, Chatterjee A. Potentiating antibiotics in drug-resistant clinical isolates via stimuli-activated superoxide generation. Science Advances. 2017;3:e1701776
• 24. Frasca K, Jose Castillo-Mancilla J, McNulty MC, Susan Connors A, Sweitzer E, Zimmer S, Madinger N. A Mixed Methods Evaluation of an Inclusive Sexual History Taking and HIV Prevention Curriculum for Trainees. J Gen Intern Med. 2019 Jul;34(7):1279-1288
• 25. Pfumojena S, Madinger N, Katsidzira L. Patterns of Hepatitis B and C exposure, susceptibility and vaccination status among Hepatitis B and C exposure, susceptibility and vaccination status among healthcare workers at Parirenyatwa Hospital, Zimbabwe. Central African Med J. 2019;65:30-34
• Mann S, Purohit S, Tobolowsky F, Henao-Martínez A, Bajrovic V, Ramanan P, Wolfel E, Khazanie P, Barron M, Madinger N, Benamu E. Cryptococcal Pericarditis in a Heart Transplant Recipient" Trans Infect Dis. 2020;22(6):e13366
• Chatterjee, et al. Facile Accelerated Specific Therapeutic (FAST) Platform Develops Peptide Nucleic Acid Therapies to Counter Multidrug-Resistant Bacteria. CommBio.2021, accepted
• Goodman A, Patten L, Castillo-Mancilla J, Zimmer S, Madinger N, Frasca K. Factors Associated with Retention and Adherence in a Comprehensive, Diverse HIV Pre-Exposure Prophylaxis Clinic. AIDS Res Hum Retroviruses. 2022 Jan 6. [Epub ahead of print] PubMed PMID: 34861765
• Eller KA, Aunins TR, Courtney CM, Campos JK, Otoupal PB, Erickson KE, Madinger NE, Chatterjee A. Facile accelerated specific therapeutic (FAST) platform develops antisense therapies to counter multidrug-resistant bacteria. Commun Biol. 2021 Mar 12;4(1):331. PubMed PMID: 33712689
• Goodman A, Patten L, Castillo Mancilla J, Zimmer S, Madinger N, Frasca K. Factors associated with retention and adherence in a comprehensive, diverse HIV Pre-Exposure Prophylaxis (PrEP) clinic. AIDS Research and Human Retroviruses. 2022;38:327-335
• Unterborn R, Henao-Cordero J, Kousari A, Ramanan P, Franco-Paredes C, Madinger N. False-positive rapid diagnostic test for malaria in new world cutaneous leishmaniasis: a tale of two travelers. Ther Adv Infect Dis. 2022 Jan-Dec; 9: 20499361221097791 PMID: 35572813 PMCID: PMC9092576 DOI: 10.1177/20499361221097791
• Shepard Z, Vargas Barahona L, Montalbano G, Rowan SE, Franco-Paredes C, Madinger N. Bartonella quintana Infection in People Experiencing Homelessness in the Denver Metropolitan Area. J Infect Dis. 2022;225:jiac238. doi: 10.1093/infdis/jiac238. PMID: 35749315

Practice Locations

UCHealth University of Colorado Hospital (UCH)
12605 E. 16th Ave
Aurora, CO 80045
720-848-0000

Hospital Affiliation

• University of Colorado Hospital

Specialty Information

Specialties

• Infectious Disease, Board Certification (1990, 2010)
• Internal Medicine, Board Certification (1987)

Conditions & Treatments

• Immune System - AIDS / HIV Disease
• Infections - Viral Infections
• Infections - Sexually Transmitted Diseases
• Infections - Pneumonia
• Infections - Influenza
• Infections - Fungal Infections
• Infections - Bacterial Infections
• Immune System - AIDS
• Immune System - AIDS Immunization
• Immune System - Immunodeficiency
• Kidneys and Urinary System - Kidney Infection
• Brain and Nervous System - Meningitis
• Brain and Nervous System
• Immune System
• Infections
• Kidneys and Urinary System